South San Francisco

10–100 Companies
More info
Related cities
10–100 companies in South San Francisco
Show all
Genentech

Genentech

Biotechnology
MyoKardia

MyoKardia

Biotechnology
insitro

insitro

Biotechnology +2
Freenome

Freenome

Personal Health +2
SuccessFactors

SuccessFactors

Enterprise Software +3
Plenty

Plenty

Big Data +2
Sutro Biopharma

Sutro Biopharma

Biotechnology
Theravance

Theravance

Biotechnology
Dispatch

Dispatch

Robotics +2
Counsyl

Counsyl

Machine Learning +3
Kinestral Technologies, Inc.

Kinestral Technologies, Inc.

Hardware +1
CytoVale

CytoVale

Biotechnology
Veracyte, Inc.

Veracyte, Inc.

Health Care +1
Principia Biopharma

Principia Biopharma

Biotechnology
Titan Pharma

Titan Pharma

Medical +1
All companies in South San Francisco
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Filter companies
Companies
58
Growing
Add companies
Deals 2020 Q4
1 investment
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Upgrade account
neurons.AI

BMS joins forces with insitro to develop neurodegenerative treatments

insitro
insitro
neurons.AI

insitro Bolsters Machine–Learning Platform with Haystack Sciences Acquisition

neurons.AI

Koller’s insitro snaps up Haystack to build up machine learning tech

$140,000,000 Venture capital (Series D)
TechCrunch

Plenty has raised over $500 million to grow fruits and veggies indoors

Plenty
Plenty
Xconomy

Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B

MyoKardia
MyoKardia
Xconomy

Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More

Freenome
Freenome
$270,000,000 Venture capital (Series C)
FinSMEs , ChinaMoneyNetwork

Freenome Closes $270M Series C Financing

Freenome
Freenome
Xconomy

Genentech Gets FDA OK for Injectable Rare Neuroimmune Disease Drug

Genentech
Genentech
Xconomy

Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia

MyoKardia
MyoKardia
BridgeBio
BridgeBio
Perceptive Advisors
Perceptive Advisors
$135,000,000 Venture capital (Series D)
FinSMEs , Pulse 2.0

Encoded Therapeutics Raises $135M in Series D Financing

Encoded Genomics Inc
Encoded Genomics Inc
$143,000,000 Venture capital (Series B)
FinSMEs , neurons.AI , PrivateEquityWire , +1

insitro Raises $143M in Series B Financing

insitro
insitro
$60,000,000 Venture capital (Series A)
WSJ Venture Capital , FinSMEs

Cancer Drugmaker Day One Biopharmaceuticals Launches With $60 Million

Day One Biopharmaceuticals
Day One Biopharmaceuticals
the home of AI info

Scientist, Neuroscience : South San Francisco | Genentech RnD Jobs

Genentech
Genentech
Xconomy

MyoKardia’s Heart Drug Shines in Phase 3, FDA Filing Planned for 2021

MyoKardia
MyoKardia
TechCrunch

The Dispatch, a news organization built on Substack, passes $1M in annual revenue

Dispatch
Dispatch
Xconomy

Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact

the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...

MyoKardia
MyoKardia
the home of AI info

Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...

MyoKardia
MyoKardia
$15,000,000 Venture capital (Series B)
the home of AI info , the home of AI info

Business Briefs: Cytovale Announces $15 Million in Financing

CytoVale
CytoVale
the home of AI info

Roche/Genentech Partnering Team: One Face For The World To See